Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06278558

Psychological Factors Influencing Cancer Post-traumatic Growth

Study of the Psychological Factors Influencing Post-traumatic Growth During Oncological Pathway

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
289 (estimated)
Sponsor
Centre Hospitalier de Valenciennes · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study focuses on post-traumatic growth (positive changes linked to appreciation of life, personal strengths, social relationships...) in the context of different types of cancer and with a longitudinal approach to the care pathway. The aim of the study is to better understand whether psychological variables (emotional competence, psychological flexibility, psychological distress) and patients' care satisfaction, assessed at the start of the cancer treatment pathway, can influence their post-traumatic growth at the end of the chemotherapy protocol and 6 months later.

Conditions

Interventions

TypeNameDescription
OTHERInterviews with a psychologist/psychiatristAll patients with a high score (≥11) on the HADS anxiety and/or depressive symptoms scale and who are not already receiving known psychological treatment or treatment mentioned in the file will be contacted by telephone by the investigator or a qualified person designated by him/her in order to conduct a telephone interview with the patient and refer him/her to a psychologist or psychiatrist if necessary. The number and percentage of consultations with a psychologist or psychiatrist following this telephone interview will be calculated in order to highlight the benefits of such a practice (HADS assessment + telephone interview with +/- referral) for earlier and easier referral. Depending on the number of patients contacted, consideration may be given to testing the effect of this approach on post-traumatic development.

Timeline

Start date
2023-11-10
Primary completion
2026-11-10
Completion
2027-11-10
First posted
2024-02-26
Last updated
2025-03-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06278558. Inclusion in this directory is not an endorsement.